Loading...
Clariane SE
CLARI.PA•EURONEXT
Healthcare
Medical - Care Facilities
€4.43
€-0.13(-2.77%)
Clariane SE (CLARI.PA) Financial Performance & Income Statement Overview
Review Clariane SE’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.73%
↑ 5.73%
Operating Income Growth
60.57%
↑ 60.57%
Net Income Growth
47.62%
↑ 47.62%
Operating Cash Flow Growth
12.93%
↑ 12.93%
Operating Margin
5.18%
↑ 5.18%
Gross Margin
18.85%
↑ 18.85%
Net Profit Margin
-0.35%
↓ 0.35%
ROE
-0.38%
↓ 0.38%
ROIC
1.81%
↑ 1.81%
Clariane SE (CLARI.PA) Income Statement & Financial Overview
Review Clariane SE's (CLARI.PA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $2.65B | $1.31B | $2.56B | $1.27B |
| Cost of Revenue | $2.31B | $900.80M | $2.21B | $850.42M |
| Gross Profit | $333.03M | $413.26M | $355.94M | $420.51M |
| Gross Profit Ratio | $0.13 | $0.31 | $0.14 | $0.33 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $111.83M | $144.26M | $116.20M | $138.31M |
| Operating Expenses | $188.55M | $352.48M | $172.41M | $397.33M |
| Total Costs & Expenses | -$2.50B | $1.25B | $2.38B | $1.25B |
| Interest Income | $9.40M | $0.00 | $0.00 | $13.58M |
| Interest Expense | $167.50M | $168.93M | $0.00 | $0.00 |
| Depreciation & Amortization | $364.73M | $57.44M | $345.47M | $97.37M |
| EBITDA | $521.85M | $124.74M | $408.42M | $192.61M |
| EBITDA Ratio | $0.20 | $0.09 | $0.21 | $0.15 |
| Operating Income | $144.48M | $60.78M | $183.53M | $87.07M |
| Operating Income Ratio | $0.05 | $0.05 | $0.07 | $0.07 |
| Other Income/Expenses (Net) | -$154.85M | -$74.25M | -$279.19M | -$72.07M |
| Income Before Tax | -$10.37M | -$13.47M | -$95.67M | -$51.24M |
| Income Before Tax Ratio | -$0.004 | -$0.01 | -$0.04 | -$0.04 |
| Income Tax Expense | -$2.64M | -$6.81M | -$7.34M | $3.67M |
| Net Income | $12.32M | -$26.13M | -$106.45M | -$50.13M |
| Net Income Ratio | $0.005 | -$0.02 | -$0.04 | -$0.04 |
| EPS | $0.06 | -$0.07 | -$1.00 | -$0.45 |
| Diluted EPS | $0.07 | -$0.18 | -$1.00 | -$0.44 |
| Weighted Avg Shares Outstanding | $216.15M | $200.91M | $106.53M | $111.75M |
| Weighted Avg Shares Outstanding (Diluted) | $174.18M | $145.58M | $106.53M | $113.49M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan